You are here

Barry T. Katzen, MD
 - Medtronic Symplicity renal denervation system

Medical advances are announced at breakneck speed, many heralded as the greatest breakthrough since antibiotics or anesthesia. Although most don’t live up to the hype, some find a valuable if limited role in the clinician’s arsenal. Renal sympathetic denervation may prove to be one of those.

 - Barry T. Katzen, MD

Approximately 30 percent of patients with an aortic aneurysm are considered too high risk for surgery yet unsuitable for existing endograft devices. Physicians are turning to extreme endovascular aneurysm repair and thoracic endovascular aneurysm repair to create solutions for these otherwise out-of-luck patients.

 - Barry T. Katzen, MD

Patient advocatesoften suffering from incurable diseaseshave become increasingly influential in pushing for the development of new therapies, and that influence has been multiplied by the internets ability to quickly spread information and connect like-minded individuals.

A variety of ills would ensue if industry support for meetings dried up.